Controversy sparks over CJ's trademark Simvasta

The ongoing discord between the Korean Intellectual Property Office and Hanmi Pharm over the CJ Corporation's trademark Simvasta (simvastatin), a lipid lowering agent, has intensified in the wake of the KIPO's recent grant on that trademark.

In addressing concerns about possible restriction to use other generic names on the part of generic manufacturers, Hanmi said it would seek a trademark ...